James Hunter
Vermögen: - $ am 31.08.2026
Vermögen: - $ am 31.08.2026
James Hunter is the founder of ReliaLAB, Inc. Current jobs include Director at Tonix Pharmaceuticals Holding Corp.
starting in 2025.
Former jobs include President & Chief Executive Officer at Validus Pharmaceuticals LLC from 2007 to 2018 and Executive Director-Northeast Business Unit at Ciba-Geigy Pharmaceuticals.
Education includes an MBA from Fairleigh Dickinson University and an undergraduate degree from Seton Hall University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.05.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Direktor/Vorstandsmitglied | 12.06.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
Validus Pharmaceuticals LLC
Validus Pharmaceuticals LLC Drugstore ChainsRetail Trade Develops and markets psychiatry and neurology products | Vorstandsvorsitzender | 01.06.2018 |
Ciba-Geigy Pharmaceuticals | Corporate Officer/Principal | - |
ReliaLAB, Inc. | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
ReliaLAB, Inc. | |
Validus Pharmaceuticals LLC
Validus Pharmaceuticals LLC Drugstore ChainsRetail Trade Develops and markets psychiatry and neurology products | Retail Trade |
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ciba-Geigy Pharmaceuticals | |
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics & diagnostics products to treat and prevent human disease and alleviate suffering | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen